AstraZeneca and Teva settle US Pulmicort case
This article was originally published in Scrip
Executive Summary
AstraZeneca and Teva Pharmaceutical Industries have settled their US legal dispute on patent infringement of the Anglo-Swedish firm's Pulmicort Respules (budesonide inhalation suspension, BIS).